...
首页> 外文期刊>Molecular cancer therapeutics >Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.
【24h】

Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.

机译:Na,K-ATPase亚基作为癌症和纤维化中上皮-间质转化的标志物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Epithelial-to-mesenchymal transition (EMT) is an important developmental process, participates in tissue repair, and occurs during pathologic processes of tumor invasiveness, metastasis, and tissue fibrosis. The molecular mechanisms leading to EMT are poorly understood. Although it is well documented that transforming growth factor (TGF)-beta plays a central role in the induction of EMT, the targets of TGF-beta signaling are poorly defined. We have shown earlier that Na,K-ATPase beta(1)-subunit levels are highly reduced in poorly differentiated kidney carcinoma cells in culture and in patients' tumor samples. In this study, we provide evidence that Na,K-ATPase is a new target of TGF-beta(1)-mediated EMT in renal epithelial cells, a model system used in studies of both cancer progression and fibrosis. We show that following treatment with TGF-beta(1), the surface expression of the beta(1)-subunit of Na,K-ATPase is reduced, before well-characterized EMT markers, and is associated with the acquisition of a mesenchymal phenotype. RNAi-mediated knockdown confirmed the specific involvement of the Na,K-ATPase beta(1)-subunit in the loss of the epithelial phenotype and exogenous overexpression of the Na,K-ATPase beta(1)-subunit attenuated TGF-beta(1)-mediated EMT. We further show that both Na,K-ATPase alpha- and beta-subunit levels are highly reduced in renal fibrotic tissues. These findings reveal for the first time that Na,K-ATPase is a target of TGF-beta(1)-mediated EMT and is associated with the progression of EMT in cancer and fibrosis.
机译:上皮-间质转化(EMT)是重要的发育过程,参与组织修复,并发生在肿瘤浸润,转移和组织纤维化的病理过程中。导致EMT的分子机制了解甚少。尽管有充分的文献证明转化生长因子(TGF)-β在EMT的诱导中起着核心作用,但是TGF-β信号转导的靶标却定义不清。我们早先已经表明,在培养物中低分化的肾癌细胞和患者的肿瘤样品中,Na,K-ATPase beta(1)-亚基水平大大降低。在这项研究中,我们提供的证据表明,Na,K-ATPase是TGF-beta(1)介导的肾上皮细胞EMT的新靶标,该模型是用于研究癌症进展和纤维化的模型系统。我们显示,用TGF-β(1)处理后,Na,K-ATPase的β(1)-亚基的表面表达在表征良好的EMT标记之前降低,并与间充质表型的获得有关。 RNAi介导的敲低证实Na,K-ATPase beta(1)-亚基的具体参与上皮表型的丧失和Na,K-ATPase beta(1)-亚基的外源性过表达减弱了TGF-beta(1 )中介的EMT。我们进一步表明,在肾纤维化组织中,Na,K-ATPaseα和β亚基水平都大大降低。这些发现首次揭示Na,K-ATPase是TGF-beta(1)介导的EMT的靶标,并且与EMT在癌症和纤维化中的进展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号